Fosrenol Powder
Product Images NDC 54092-257

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Fosrenol (NDC 54092-257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Fosrenol 01)

A line graph illustrating the dose-response relationship of Fosrenol (lanthanum carbonate) on phosphorus reduction compared to placebo. The x-axis shows increasing doses of Fosrenol (225 mg, 675 mg, 1350 mg, 2250 mg), and the y-axis shows the difference in phosphorus reduction in mg/dl, with error bars indicating variability at each dose level.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Fosrenol 500 mg chewable tablets label showing lanthanum carbonate as the active ingredient. The label includes medication instructions to chew or crush tablets completely before swallowing. Distributed by Takeda Pharmaceuticals America, Inc., with a package count of 45 tablets. The label also states storage conditions and inactive ingredients.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Package)

Fosrenol 500 mg chewable tablets packaging label by Takeda Pharmaceuticals America, Inc. Each bottle contains 45 tablets, with 2 bottles included in the package. The label emphasizes that tablets should not be swallowed whole and must be chewed or crushed before swallowing. Active ingredient is lanthanum carbonate 500 mg per tablet. The packaging includes patient and pharmacist information, storage instructions, and regulatory details.*

FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

Fosrenol chewable tablets label for 750 mg lanthanum carbonate hydrate. The label includes directions to chew or crush tablets completely before swallowing and to take with or immediately after meals. It lists active and inactive ingredients, storage instructions, package count of 15 tablets, and manufacturer Takeda Pharmaceuticals America, Inc. A barcode and NDC 54092-253-15 are also visible.*

FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Package)

Fosrenol 750 mg chewable tablets packaging label for lanthanum carbonate by Takeda Pharmaceuticals America, Inc. The label indicates 6 bottles with 15 chewable tablets each, for oral use. It includes instructions not to swallow tablets whole, but to chew or crush completely before swallowing, and to take with or immediately after meals. The label also lists active and inactive ingredients and storage directions.*

FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Label)

Fosrenol 1000 mg chewable tablets label showing the active ingredient lanthanum carbonate. The label includes directions not to swallow tablets whole and to chew or crush completely before swallowing. It lists inactive ingredients, storage instructions, package size of 10 tablets, and Takeda Pharmaceuticals America as the distributor.*

FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Package)

Packaging label for Fosrenol 1000 mg chewable tablets containing lanthanum carbonate. The label shows the product name, strength, dosage form, and instructions emphasizing not to swallow tablets whole and to chew or crush completely before swallowing. The package contains 9 bottles with 10 chewable tablets each and is labeled for prescription use only. Distributed by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Principal Display Panel (750 mg Packet Carton)

Fosrenol (lanthanum carbonate) oral powder 750 mg carton label for 10 stick packs. Label shows product name, strength, active and inactive ingredients, storage instructions, manufacturer information, and directions to mix with soft food. Distributed by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Principal Display Panel (750 mg Packet Carton)

Packaging label for Fosrenol 750 mg (lanthanum carbonate) oral powder, distributed by Takeda Pharmaceuticals America, Inc. The label indicates this prescription drug is supplied as oral powder in 9 cartons, each containing 10 stick packs. Instructions note mixing with a small quantity of soft food and taking immediately. Storage information and inactive ingredients are also provided.*

FDA Label Image

Principal Display Panel (1000 mg Packet Carton)

Box packaging label for Fosrenol (lanthanum carbonate) oral powder 1000 mg by Takeda Pharmaceuticals America, Inc. The label shows the product as oral powder in 10 stick packs with active ingredient content of 1000 mg lanthanum per carton. It includes instructions to mix with soft food and store at controlled room temperature. Manufacturer and distributor details are printed as well.*

FDA Label Image

Principal Display Panel (1000 mg Packet Carton)

Packaging label for Fosrenol (lanthanum carbonate) oral powder, 1000 mg strength. The label indicates the product is for oral use and comes in cartons containing 9 cartons, each with 10 stick packs. The labeler is Takeda Pharmaceuticals America, Inc. Instructions mention mixing with a small quantity of soft food and taking immediately. Storage and ingredient details are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.